The CDMO wants to respond to the “Growing demand for biotherapeutics. “
The Japanese group, through its subsidiary Fujifilm Diosynth Biotechnologies, has announced an investment of $ 850 million (€ 718 million) to increase its development and production capacities for biological products.
Initially, the manufacturer intends to double its production of cell cultures, intended[…]
–
Related posts:
[기상센터][날씨] Cold waves raging under the world, heavy snow on the west coast... the first day of the ...
Farmers block border crossings with Germany, more actions expected on Tuesday (update)
Worrisome disappearance in Loire-Atlantique: the young man found in the
Al Madam Cultural and Sports Club Launches Awareness Initiative for Sustainable Development in the U...
